Old Web
English
Sign In
Acemap
>
authorDetail
>
Turki A. Althunian
Turki A. Althunian
Utrecht University
Medicine
Cohort
Warfarin
Cohort study
Stroke
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Analyzing the U.S. Post-marketing safety surveillance of COVID-19 vaccines
2021
medRxiv
Omar M. Albalawi
Maha I. Alomran
Ghada M. Alsagri
Turki A. Althunian
Thamir M. Alshammari
Show All
Source
Cite
Save
Citations (0)
Assessment of the Regulatory Dialogue Between Pharmaceutical Companies and the European Medicines Agency on the Choice of Noninferiority Margins
2020
Clinical Therapeutics
Turki A. Althunian
Anthonius de Boer
Aukje K. Mantel-Teeuwisse
Rolf H.H. Groenwold
Christine C. Gispen-de Wied
Hubert G. M. Leufkens
Olaf H. Klungel
Show All
Source
Cite
Save
Citations (0)
Rivaroxaban was found to be noninferior to warfarin in routine clinical care: A retrospective noninferiority cohort replication study.
2020
Pharmacoepidemiology and Drug Safety
Turki A. Althunian
Anthonius de Boer
Rolf H.H. Groenwold
Katrien Oude Rengerink
Patrick C. Souverein
Olaf H. Klungel
Show All
Source
Cite
Save
Citations (0)
1